<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Histological preparations from 22 irradiated patients with gigantofollicular <z:mp ids='MP_0009320'>lymphoblastoma</z:mp> <z:e sem="disease" ids="C0024301" disease_type="Neoplastic Process" abbrv="">Brill-Symmers</z:e> have been reviewed and graded in accordance with the Kiel classification 1974 </plain></SENT>
<SENT sid="1" pm="."><plain>Corresponding to this, 19 patients had <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>-centrocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and three a <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> <z:hpo ids='HP_0100242'>sarcoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In the three sub-groups of <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>-centrocylic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, no essential differences were found in stages I-III with respect to anamnesis or clinical findings before the <z:hpo ids='HP_0003674'>onset</z:hpo> of treatment, or to the previous course of the disease </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">Centroblastic</z:e> <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, ranging among the <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with a high degree of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, has manifested unfavorable progressive courses in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
</text></document>